{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:05:32Z","timestamp":1789639532591,"version":"4.0.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460282"],"award-info":[{"award-number":["82460282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["Qiankehe Jichu MS [2025] 025"],"award-info":[{"award-number":["Qiankehe Jichu MS [2025] 025"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Negative symptoms, particularly avolition and asociality, rank among the most disabling and treatment-resistant features of schizophrenia-spectrum disorders. Clinician-rated scales such as the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale have strengthened construct definition. However, they depend on infrequent interviews and retrospective recall, missing the moment-to-moment behavioral patterns that define these symptoms in everyday life. Passive digital phenotyping, through smartphones and wearable sensors, can continuously capture mobility, physical activity, sleep, social rhythms, and speech acoustics under real-world conditions. Whether artificial intelligence can convert these noisy, incomplete, and context-dependent data streams into clinically valid digital endpoints remains the central unresolved question. This narrative review synthesizes evidence on AI-enabled passive digital phenotyping of experiential negative symptoms in schizophrenia-spectrum disorders. We propose a construct-to-endpoint pipeline that links construct definition, multimodal representation learning, and fit-for-purpose clinical validation to interpretable digital markers and just-in-time adaptive interventions. Current evidence reveals consistent but modest associations between passive sensing modalities and negative symptoms. However, single-modality correlations do not constitute valid endpoints. A qualified digital endpoint must demonstrate analytical validity, clinical validity, longitudinal sensitivity, external transportability, and patient meaningfulness. Key challenges span data-level issues such as resolution mismatch and device heterogeneity, inferential risks including environmental confounding and algorithmic bias, and ethical-regulatory concerns involving privacy and model opacity. The field should now prioritize construct-anchored, context-aware, and interpretable digital endpoints that can serve as outcome measures in negative-symptom trials and support personalized longitudinal monitoring.<\/jats:p>","DOI":"10.3389\/fpsyt.2026.1898444","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:53:15Z","timestamp":1789638795000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["AI-enabled passive digital phenotyping of experiential negative symptoms in schizophrenia-spectrum disorders: a narrative review on the path from sensing to clinical endpoints"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanping","family":"Shu","sequence":"first","affiliation":[{"name":"Department of Women and Child Psychiatry, The Second People\u2019s Hospital of Guizhou Province","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifan","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Digital Economy and Finance, Guizhou University of Commerce","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Women and Child Psychiatry, The Second People\u2019s Hospital of Guizhou Province","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuli","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Women and Child Psychiatry, The Second People\u2019s Hospital of Guizhou Province","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Medical Humanities, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanrong","family":"Wen","sequence":"additional","affiliation":[{"name":"School of Psychology, Guizhou Normal University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Tan","sequence":"additional","affiliation":[{"name":"School of Psychology, Guizhou Normal University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-025-00667-6","article-title":"Schizophrenia","volume":"11","author":"Leucht","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.euroneuro.2013.10.017","article-title":"Negative symptoms of schizophrenia: Clinical features, relevance to real world functioning and specificity versus other CNS disorders","volume":"24","author":"Foussias","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.11","article-title":"EPA guidance on assessment of negative symptoms in schizophrenia","volume":"64","author":"Galderisi","year":"2021","journal-title":"Eur Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2012.12010109","article-title":"The clinical assessment interview for negative symptoms (CAINS): final development and validation","volume":"170","author":"Kring","year":"2013","journal-title":"Am J Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.06.030","article-title":"Development and psychometric validation of the clinical assessment interview for negative symptoms (CAINS)","volume":"132","author":"Horan","year":"2011","journal-title":"Schizophr Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw046","article-title":"A psychometric comparison of the clinical assessment interview for negative symptoms and the brief negative symptom scale","volume":"42","author":"Strauss","year":"2016","journal-title":"Schizophr Bull"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbad137","article-title":"Clinical assessment interview for negative symptoms (CAINS): A systematic review of measurement properties","volume":"50","author":"Wehr","year":"2024","journal-title":"Schizophr Bull"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/schbul\/sbae168","article-title":"Clinician-reported negative symptom scales: A systematic review of measurement properties","volume":"51","author":"Weigel","year":"2025","journal-title":"Schizophr Bull"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15010083","article-title":"Assessment of negative symptoms in schizophrenia: From the consensus Conference-Derived scales to remote digital phenotyping","volume":"15","author":"Mucci","year":"2025","journal-title":"Brain Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11295","article-title":"Digital phenotyping: Technology for a new science of behavior","volume":"318","author":"Insel","year":"2017","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2196\/mental.5165","article-title":"New tools for new research in psychiatry: A scalable and customizable platform to empower data driven smartphone research","volume":"3","author":"Torous","year":"2016","journal-title":"JMIR Ment Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.7","article-title":"Harnessing smartphone-based digital phenotyping to enhance behavioral and mental health","volume":"41","author":"Onnela","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41746-019-0166-1","article-title":"Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety","volume":"2","author":"Huckvale","year":"2019","journal-title":"NPJ Digit Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgad001","article-title":"Remote assessment of negative symptoms of schizophrenia","volume":"4","author":"Daniel","year":"2023","journal-title":"Schizophr Bull Open"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgae027","article-title":"Rationale and challenges for a new instrument for remote measurement of negative symptoms","volume":"5","author":"Daniel","year":"2024","journal-title":"Schizophr Bull Open"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21299","article-title":"The evolving field of digital mental health: Current evidence and implementation issues for smartphone apps, generative artificial intelligence, and virtual reality","volume":"24","author":"Torous","year":"2025","journal-title":"World Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41746-025-02194-w","article-title":"Diagnostic digital phenotyping in schizophrenia-spectrum disorders: A systematic review","volume":"9","author":"Vecchio","year":"2026","journal-title":"NPJ Digit Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2025.05.019","article-title":"Smartphone monitoring and digital phenotyping apps for schizophrenia: A review of the academic literature","volume":"281","author":"Hau","year":"2025","journal-title":"Schizophr Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/HRP.0000000000000268","article-title":"Systematic review of digital phenotyping and machine learning in psychosis spectrum illnesses","volume":"28","author":"Benoit","year":"2020","journal-title":"Harv Rev Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12888-026-08157-z","article-title":"Digital phenotyping for predicting relapse in psychiatric disorders: A systematic review of passive sensing approaches","volume":"26","author":"Fang","year":"2026","journal-title":"BMC Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.2475","article-title":"The latent structure of negative symptoms in schizophrenia","volume":"75","author":"Strauss","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2022.08.016","article-title":"Revisiting the latent structure of negative symptoms in schizophrenia: Evidence from two second-generation clinical assessments","volume":"248","author":"Li","year":"2022","journal-title":"Schizophr Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2024.07.043","article-title":"Social anhedonia in the daily lives of people with schizophrenia: Examination of anticipated and consummatory pleasure","volume":"271","author":"Abel","year":"2024","journal-title":"Schizophr Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2023.02.037","article-title":"Negative symptoms in schizophrenia differ across environmental contexts in daily life","volume":"161","author":"Luther","year":"2023","journal-title":"J Psychiatr Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291723001393","article-title":"Environmental context predicts state fluctuations in negative symptoms in youth at clinical high risk for psychosis","volume":"53","author":"Luther","year":"2023","journal-title":"Psychol Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1037\/abn0000240","article-title":"Ecological momentary assessment of negative symptoms in schizophrenia: Relationships to effort-based decision making and reinforcement learning","volume":"126","author":"Moran","year":"2017","journal-title":"J Abnorm Psychol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/2167702620901558","article-title":"Effort, avolition and motivational experience in schizophrenia: Analysis of behavioral and neuroimaging data with relationships to daily motivational experience","volume":"8","author":"Culbreth","year":"2020","journal-title":"Clin Psychol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbae128","article-title":"The role of defeatist performance beliefs in state fluctuations of negative symptoms in schizophrenia measured in daily life via ecological momentary assessment","volume":"50","author":"Luther","year":"2024","journal-title":"Schizophr Bull"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.114996","article-title":"Effort-cost decision-making associated with negative symptoms in schizophrenia and bipolar disorder","volume":"467","author":"Is\u0131kl\u0131","year":"2024","journal-title":"Behav Brain Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2022.11.019","article-title":"A closer look at avolition in schizophrenia and bipolar disorder: Persistence of different types of activities over time","volume":"250","author":"Martinuzzi","year":"2022","journal-title":"Schizophr Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.8292","article-title":"Capturing Rest-Activity profiles in schizophrenia using wearable and mobile technologies: Development, implementation, feasibility, and acceptability of a remote monitoring platform","volume":"6","author":"Meyer","year":"2018","journal-title":"JMIR Mhealth Uhealth"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2196\/56185","article-title":"Utility of digital phenotyping based on wrist wearables and smartphones in psychosis: Observational study","volume":"13","author":"Yang","year":"2025","journal-title":"JMIR Mhealth Uhealth"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2196\/75774","article-title":"Smartwatch-Derived digital phenotypes relate to psychopathology dimensions in patients with psychotic spectrum disorders: Longitudinal observational study","volume":"12","author":"Garyfalli","year":"2025","journal-title":"JMIR Ment Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2021.04.022","article-title":"Digital phenotyping adherence, feasibility, and tolerability in outpatients with schizophrenia","volume":"138","author":"Raugh","year":"2021","journal-title":"J Psychiatr Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2025.07.009","article-title":"Digital phenotyping correlates of cognitive performance in schizophrenia spectrum disorders from a longitudinal study","volume":"283","author":"Das","year":"2025","journal-title":"Schizophr Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbaa121","article-title":"Geolocation as a digital phenotyping measure of negative symptoms and functional outcome","volume":"46","author":"Raugh","year":"2020","journal-title":"Schizophr Bull"},{"key":"B37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.schres.2020.10.002","article-title":"Emotional determinants of life-space through GPS and ecological momentary assessment in schizophrenia: What gets people out of the house","volume":"224","author":"Parrish","year":"2020","journal-title":"Schizophr Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41746-019-0182-1","article-title":"GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study","volume":"2","author":"Depp","year":"2019","journal-title":"NPJ Digit Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1037\/abn0001037","article-title":"Geolocation-derived mobility indices and the association with clinical symptoms and functioning in severe mental illness: A multivariate meta-analysis","volume":"134","author":"Filip","year":"2025","journal-title":"J Psychopathol Clin Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2026.02.019","article-title":"Motor activity-based prediction of the presence of apathy in schizophrenia","volume":"292","author":"Deng","year":"2026","journal-title":"Schizophr Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/abn0001000","article-title":"Passive sensing of anhedonia and amotivation in a transdiagnostic sample","volume":"134","author":"Culbreth","year":"2025","journal-title":"J Psychopathol Clin Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-024-02804-0","article-title":"Social network reductions are associated with negative symptoms in schizophrenia","volume":"60","author":"Zhang","year":"2025","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbae032","article-title":"Intensive longitudinal social sensing in patients with psychosis spectrum disorders: An exploratory pilot study","volume":"51","author":"von Heyden","year":"2025","journal-title":"Schizophr Bull"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbae022","article-title":"Loneliness in the daily lives of people with mood and psychotic disorders","volume":"50","author":"Moran","year":"2024","journal-title":"Schizophr Bull"},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s44277-025-00034-z","article-title":"Automated speech and language markers of longitudinal changes in psychosis symptoms","volume":"3","author":"Tang","year":"2025","journal-title":"NPP Digit Psychiatry Neurosci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1571647","article-title":"Measurement of schizophrenia symptoms through speech analysis from PANSS interview recordings","volume":"16","author":"Worthington","year":"2025","journal-title":"Front Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41537-025-00669-z","article-title":"Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP\u00ae SCZ initiative","volume":"11","author":"Bilgrami","year":"2025","journal-title":"Schizophr (Heidelb)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbac128","article-title":"Voice patterns as markers of schizophrenia: Building a cumulative generalizable approach via a Cross-Linguistic and meta-analysis based investigation","volume":"49","author":"Parola","year":"2023","journal-title":"Schizophr Bull"},{"key":"B49","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jpsychires.2026.04.007","article-title":"Ethnoracially incongruent environments predict state increases in negative symptoms of schizophrenia: Evidence from geocoding and digital phenotyping","volume":"198","author":"James","year":"2026","journal-title":"J Psychiatr Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbab134","article-title":"Machine learning identifies digital phenotyping measures most relevant to negative symptoms in psychotic disorders: Implications for clinical trials","volume":"48","author":"Narkhede","year":"2022","journal-title":"Schizophr Bull"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266516","article-title":"Machine learning for passive mental health symptom prediction: Generalization across different longitudinal mobile sensing studies","volume":"17","author":"Adler","year":"2022","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01981-2","article-title":"Multimodal biomedical AI","volume":"28","author":"Acosta","year":"2022","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in health and medicine","volume":"28","author":"Rajpurkar","year":"2022","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-022-00914-1","article-title":"Self-supervised learning in medicine and healthcare","volume":"6","author":"Krishnan","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41746-024-01062-3","article-title":"Self-supervised learning for human activity recognition using 700,000 person-days of wearable data","volume":"7","author":"Yuan","year":"2024","journal-title":"NPJ Digit Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41746-020-0260-4","article-title":"Verification, analytical validation, and clinical validation (V3): The foundation of determining fit-for-purpose for biometric monitoring technologies (BioMeTs)","volume":"3","author":"Goldsack","year":"2020","journal-title":"NPJ Digit Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1124\/pr.120.000028","article-title":"Development of novel, Value-Based, digital endpoints for clinical trials: A structured approach toward fit-for-purpose validation","volume":"72","author":"Kruizinga","year":"2020","journal-title":"Pharmacol Rev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B59","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s43856-025-01013-3","article-title":"Challenges and standardisation strategies for sensor-based data collection for digital phenotyping","volume":"5","author":"Alam","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2196\/58502","article-title":"Transforming digital phenotyping raw data into actionable biomarkers, quality metrics, and data visualizations using cortex software package: Tutorial","volume":"26","author":"Burns","year":"2024","journal-title":"J Med Internet Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2023-300718","article-title":"Increasing the value of digital phenotyping through reducing missingness: a retrospective review and analysis of prior studies","volume":"26","author":"Currey","year":"2023","journal-title":"BMJ Ment Health"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20703","article-title":"Validating digital phenotyping technologies for clinical use: The critical importance of resolution","volume":"19","author":"Cohen","year":"2020","journal-title":"World Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13786","article-title":"Digital phenotyping of social functioning and employment in people with schizophrenia: Pilot data from an international sample","volume":"79","author":"Lane","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/schbul\/sbaa065","article-title":"Digital phenotyping of negative symptoms: The relationship to clinician ratings","volume":"47","author":"Cohen","year":"2021","journal-title":"Schizophr Bull"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.826465","article-title":"European validation of the Self-Evaluation of Negative Symptoms (SNS): A large multinational and multicenter study","volume":"13","author":"Dollfus","year":"2022","journal-title":"Front Psychiatry"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.12.001","article-title":"Defining therapeutic benefit for people with schizophrenia: Focus on negative symptoms","volume":"162","author":"Schooler","year":"2015","journal-title":"Schizophr Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.10.016","article-title":"Defining and measuring negative symptoms of schizophrenia in clinical trials","volume":"24","author":"Marder","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"B68","unstructured":"Digital Health Technologies for Remote Data Acquisition in Clinical Investigations: Guidance for Industry, Investigators, and Other Stakeholders\n          \n          \n          \n          2023"},{"key":"B69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.schres.2025.04.029","article-title":"Digital phenotyping evidence for the reduced positivity offset as a mechanism underlying anhedonia among individuals at clinical high-risk for psychosis","volume":"281","author":"Bartolomeo","year":"2025","journal-title":"Schizophr Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.schres.2026.04.013","article-title":"Effects of xanomeline and trospium chloride for negative symptoms associated with physical activity in younger and older adults with schizophrenia: Results from a 52-Week, open-label clinical trial","volume":"294","author":"Harvey","year":"2026","journal-title":"Schizophr Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2025.01.019","article-title":"Capturing changes in social functioning and positive affect using ecological momentary assessment during a 12-month trial of xanomeline and trospium chloride in schizophrenia","volume":"276","author":"Harvey","year":"2025","journal-title":"Schizophr Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41537-025-00659-1","article-title":"Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: Results from an exploratory study","volume":"11","author":"Goenjian","year":"2025","journal-title":"Schizophr (Heidelb)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2196\/81293","article-title":"Effectiveness, engagement, and safety of a digital therapeutic (CT-155\/BI 3972080) for treating negative symptoms in people with schizophrenia: Protocol for the phase 3 CONVOKE randomized controlled trial","volume":"14","author":"Lakhan","year":"2025","journal-title":"JMIR Res Protoc"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgaf028","article-title":"Patient perspectives on a digital therapeutic for schizophrenia: A qualitative evaluation of an app for negative symptoms","volume":"6","author":"Gandhi","year":"2025","journal-title":"Schizophr Bull Open"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2025.07.007","article-title":"Ecological and momentary assessment and intervention for schizophrenia: Use of smartphone apps and video games","volume":"283","author":"Sakurai","year":"2025","journal-title":"Schizophr Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/eip.70119","article-title":"Preliminary findings from an augmented reality (AR) app delivering Recovery-Oriented cognitive therapy for negative symptoms in schizophrenia","volume":"20","author":"Tang","year":"2026","journal-title":"Early Interv Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1177\/20552076231222097","article-title":"Evaluating a smartphone-based symptom self-monitoring app for psychosis in China (YouXin): A non-randomised validity and feasibility study with a mixed-methods design","volume":"10","author":"Zhang","year":"2024","journal-title":"Digit Health"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251317556","article-title":"Validity of a smartphone application for self-monitoring psychiatric symptoms in patients with schizophrenia","volume":"11","author":"Kim","year":"2025","journal-title":"Digit Health"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s12160-016-9830-8","article-title":"Just-in-time adaptive interventions (JITAIs) in mobile health: Key components and design principles for ongoing health behavior support","volume":"52","author":"Nahum-Shani","year":"2018","journal-title":"Ann Behav Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2024.06.026","article-title":"Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia","volume":"96","author":"Fulford","year":"2024","journal-title":"Biol Psychiatry"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0030-z","article-title":"Relapse prediction in schizophrenia through digital phenotyping: a pilot study","volume":"43","author":"Barnett","year":"2018","journal-title":"Neuropsychopharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720004857","article-title":"The temporal dynamics of sleep disturbance and psychopathology in psychosis: a digital sampling study","volume":"52","author":"Meyer","year":"2021","journal-title":"Psychol Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41746-018-0075-8","article-title":"Data mining for health: staking out the ethical territory of digital phenotyping","volume":"1","author":"Martinez-Martin","year":"2018","journal-title":"NPJ Digit Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/15265161.2023.2180109","article-title":"Returning individual research results from digital phenotyping in psychiatry","volume":"24","author":"Shen","year":"2024","journal-title":"Am J Bioeth"},{"key":"B85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s44277-024-00017-6","article-title":"Aligning digital biomarker definitions in psychiatry with the national institute of mental health research domain criteria framework","volume":"2","author":"Mulinari","year":"2024","journal-title":"NPP Digit Psychiatry Neurosci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12888-024-05687-2","article-title":"Acceptability and experience of a smartphone symptom monitoring app for people with psychosis in China (YouXin): A qualitative study","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20593","article-title":"Using biobehavioral technologies to effectively advance research on negative symptoms","volume":"18","author":"Cohen","year":"2019","journal-title":"World Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.503323","article-title":"Validating biobehavioral technologies for use in clinical psychiatry","volume":"12","author":"Cohen","year":"2021","journal-title":"Front Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1034-x","article-title":"Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension","volume":"26","author":"Liu","year":"2020","journal-title":"Nat Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1037-7","article-title":"Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension","volume":"26","author":"Cruz Rivera","year":"2020","journal-title":"Nat Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41467-024-45355-3","article-title":"Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines","volume":"15","author":"Martindale","year":"2024","journal-title":"Nat Commun"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1898444\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:53:17Z","timestamp":1789638797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1898444\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":91,"alternative-id":["10.3389\/fpsyt.2026.1898444"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1898444","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1898444"}}